Advanced search
Publication Cover
Renal Failure Volume 45, 2023 - Issue 1
Submit an article Journal homepage
1,606
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Tubular basement membrane amyloid deposition: is it an indicator of renal progression in light chain amyloidosis?

Csilla Markótha Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary;b Kálmán Laki Doctoral School, University of Debrecen, Debrecen, HungaryCorrespondence[email protected]
View further author information
,
László Bidigab Kálmán Laki Doctoral School, University of Debrecen, Debrecen, Hungary;c Institute of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, HungaryView further author information
,
László Váróczyd Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, HungaryView further author information
,
Ibolya Filea Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, HungaryView further author information
,
József Ballaa Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary;b Kálmán Laki Doctoral School, University of Debrecen, Debrecen, HungaryView further author information
&
János Mátyusa Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary;b Kálmán Laki Doctoral School, University of Debrecen, Debrecen, HungaryView further author information
Article: 2203776 | Received 28 Feb 2023, Accepted 12 Apr 2023, Published online: 26 Apr 2023

References

  • Hopfer H, Wiech T, Mihatsch MJ. Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type. Nephrol Dial Transplant. 2011;26(9):1–6.
  • Eirin A, Irazabal MV, Gertz MA, et al. Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney. Nephrol Dial Transplant. 2012;27(3):1097–1101.
  • Rubinstein S, Cornell RF, Du L, et al. Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis. Amyloid. 2017;24(3):205–211.
  • Hoelbeek JJ, Kers J, Steenbergen EJ, et al. Renal amyloidosis: validation of a proposed histological scoring system in an independent cohort. Clin Kidney J. 2021;14(3):855–862.
  • Rezk T, Salota R, Gan JJ, et al. Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis. Br J Haematol. 2021;194(6):1016–1023.
  • Said SM, Best Rocha A, Valeri AM, et al. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis. Kidney Int. 2022;101(1):152–163.
  • Fan Y, Liang D, Rui H, et al. Using digital whole-slide images to evaluate renal amyloid deposition and its association with clinical features and outcomes of AL amyloidosis. J Nephrol. 2021;34(5):1747–1756.
  • Said SM, Sethi S, Valeri AM, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol. 2013;8(9):1515–1523.
  • Hiki Y, Horii A, Kokubo T, et al. A case of rheumatoid arthritis with renal tubular amyloidosis. Nephron. 1994;68(3):394–395.
  • Kuroda T, Ito Y, Imai N, et al. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens from patients with AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis. Amyloid. 2019;26(sup1):125–126.
  • Kuroda T, Tanabe N, Kobayashi D, et al. Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis. BMC Nephrol. 2012;13:118.
  • Sohar E, Ravid M, Ben-Shaul Y, et al. Diabetic fibrillosis. Am J Med. 1970;49(1):64–69.
  • Herrera GA, Turbat-Herrera EA. Renal diseases with organized deposits: an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med. 2010;134(4):512–531.
  • Nevone A, Girelli M, Mangiacavalli S, et al. An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis. Leukemia. 2022;36(8):2076–2085.
  • Zhu L, Wang L, Shi H, et al. Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review. Ren Fail. 2023;45(1):2145970.
  • Larsen CP, Borrelli GS, Walker PD. Amyloid proximal tubulopathy: a novel form of light chain proximal tubulopathy. Clin Kidney J. 2012;5(2):130–132.
  • Gibier JB, Gnemmi V, Glowacki F, et al. Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis. Mod Pathol. 2018;31(3):452–462.
  • Asmundsson P, Snaedal J. Persistent water diuresis in renal amyloidosis. A case report. Scand J Urol Nephrol. 1981;15(1):77–79.
  • Inoue R, Fujigaki Y, Kobayashi K, et al. Clinical presentation of tubulointerstitial nephritis caused by amyloid light-chain amyloidosis in a patient with Sjögren’s syndrome. Intern Med. 2017;56(4):419–423.
  • Hill GS, Morel-Maroger L, Méry JP, et al. Renal lesions in multiple myeloma: their relationship to associated protein abnormalities. Am J Kidney Dis. 1983;2(4):423–438.
  • Troxell ML, Griffiths R, Schnadig I, et al. Light chain renal amyloidosis with prominent giant cells. Am J Kidney Dis. 2013;62(6):1193–1197.
  • Poshusta TL, Sikkink LA, Leung N, et al. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis. PLoS One. 2009;4(4):e5169.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.